SCM
TRAW icon

Sarissa Capital Management’s Traws Pharma TRAW Stock Holding History

Sarissa Capital Management’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-6
Closed -$1.5M – 18
2014
Q3 		$1.5M Hold
6
– – 0.58% 14
2014
Q2 		$1.9M Hold
6
– – 0.65% 15
2014
Q1 		$2.22M Buy
+6
New +$3.61M 0.76% 12

Other funds holding TRAW

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Sarissa Capital Management's TRAW Position: Q4 2014 in Review

Sarissa Capital Management sold out of Traws Pharma (TRAW) in Q4 2014, closing a stake of 6 shares — an estimated $1.5M sold.

Sarissa Capital Management first reported a position in TRAW in Q1 2014 and held it in 3 quarters. The position peaked at $2.22M in Q1 2014. 12 funds tracked by Wall St. Rank hold TRAW as of Q4 2014.

  • Sarissa Capital Management reported no remaining Traws Pharma position as of Q4 2014 after selling out during the quarter.
  • Sarissa Capital Management sold 6 Traws Pharma shares in Q4 2014, an estimated $1.5M.
  • Sarissa Capital Management first reported a position in Traws Pharma in Q1 2014 and held it in 3 quarters.
  • Sarissa Capital Management's Traws Pharma position peaked at $2.22M in Q1 2014.
  • 12 funds tracked by Wall St. Rank held Traws Pharma as of Q4 2014.

Based on Sarissa Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.